Skip to main content

ICPE 2022 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Brooke E. Sylvester, PhD

Bristol Myers Squibb

Poster(s):

(87) Use of Immunosuppressive Drugs (ISD) and The Effectiveness of Immune Checkpoint Inhibitor (ICI) Therapy Among Patients with Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) in the United States (US)
Saturday, August 27, 2022
8:00 AM – 6:00 PM CEST